Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventor Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
  • New to patents
    • Go back
    • Overview
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Your business and patents
    • Is it patentable?
    • Are you first?
    • Why do we have patents?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Innovation against cancer
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 3227/19 (Rotigotine patch / LTS LOHMANN) 24-06-2022
Facebook X Linkedin Email

T 3227/19 (Rotigotine patch / LTS LOHMANN) 24-06-2022

European Case Law Identifier
ECLI:EP:BA:2022:T322719.20220624
Date of decision
24 June 2022
Case number
T 3227/19
Petition for review of
-
Application number
13795432.7
IPC class
A61K 9/70
A61K 31/381
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 397.51 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

MULTI-DAY PATCH FOR THE TRANSDERMAL ADMINISTRATION OF ROTIGOTINE

Applicant name
LTS Lohmann Therapie-Systeme AG
Opponent name

AMW GmbH

Hexal AG

Board
3.3.07
Headnote
-
Relevant legal provisions
European Patent Convention Art 123(2)
Rules of procedure of the Boards of Appeal Art 12(2)
Rules of procedure of the Boards of Appeal Art 13(2)
Keywords

Amendments - allowable (no)

primary object of appeal proceedings to review decision - appeal case directed to arguments on which decision was based (yes)

Amendment after summons - exceptional circumstances (no)

Catchword
-
Cited decisions
G 0009/92
G 0001/99
Citing decisions
-

I. European patent 2 922 533 ("the patent") was granted on the basis of thirty-seven claims. Independent claim 1 as granted defined:

"Transdermal therapeutic system, comprising

(a) a backing layer,

(b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and

(c) a release liner,

wherein the self-adhesive matrix layer has a coating weight of about 75-400 g/m2 and comprises a reservoir layer containing about 9-25 wt.-% rotigotine based on the weight of the reservoir layer."

II. Two oppositions had been filed against the grant of the patent on the grounds that its subject-matter lacked novelty and inventive step and that the claimed invention was not sufficiently disclosed.

Appeals were filed by both opponents against the interlocutory decision of the opposition division that the patent as amended in accordance with auxiliary request 1 was found to meet the requirements of the EPC.

The decision under appeal was based on the main request relating to the patent as granted and on auxiliary request 1 filed on 10 July 2019.

Claim 1 of this auxiliary requests defines:

"Transdermal therapeutic system, comprising

(a) a backing layer,

(b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and

(c) a release liner,

wherein

the self-adhesive matrix layer comprises a reservoir layer,

the reservoir layer has a coating weight of 150 g/m2 and contains 9 wt.-% or 18 wt.-% rotigotine based on the weight of the reservoir layer, and

the reservoir layer further contains polyvinyl-pyrrolidone and the rotigotine to polyvinylpyrrolidone weight ratio in the layer is 9:2 to 9:5 or multiples thereof."

III. The opposition division arrived at the following conclusions:

(a) The subject-matter of claim 1 and claim 25 as granted lacked novelty.

(b) Claim 1 of auxiliary request 1 related to a transdermal therapeutic system (TTS) comprising rotigotine as active ingredient in a reservoir layer as defined in claim 1 as granted with restriction of the rotigotine concentration to 9 wt.% or 18 wt.%, specification of the coating weight as 150 g/m**(2) and introduction of the definition of the presence of polyvinylpyrrolidone (PVP) in the reservoir layer in a rotigotine to PVP weight ratio of 9:2 to 9:5 or multiples thereof.

These amendments were based on the originally disclosed most preferred values for the coating weight and the rotigotine concentrations and originally disclosed values for the rotigotine to PVP weight ratio. The combination of these features represented a restriction towards the originally described core invention which did not extend beyond the content of the application as originally filed.

(c) The subject-matter of claim 1 of auxiliary request 1 was new over the prior art in view of the combination of features concerning the rotigotine to PVP weight ratio and the coating weight.

(d) In view of the results of the vivo study reported in the patent, which indicated a drug saving effect from patches as defined in the claims, the problem to be solved in view of the closest prior art identified as WO 2011/076879 (D3) was seen in the provision of an improved TTS which allows bio-equivalent administration of rotigotin for at least 3-7 days using minor total drug amounts with respect to the use of corresponding single-day patches. The prior art indicated that a 7-day patch required a higher drug content. It was unexpected that the value of 150 g/m**(2) in combination with a reduced drug amount still allowed to achieve bioequivalence.

Accordingly the subject-matter of auxiliary request 1 also involved an inventive step.

IV. Appellant-opponent 1 argued in its statement of grounds of appeal (see pages 7-8 section II.1.2) inter alia that claim 1 of auxiliary request 1 as filed before the opposition division did not comply with Article 123(2) EPC, because claim 1 of this request did not define the feature of the originally filed claim 1 that the matrix layer itself has a coating weight of 75-400 g/m**(2). The amendment introduced the new information that the defined coating weight applied to the reservoir layer and not to the matrix layer.

In its statement of grounds of appeal and in the letter of 3 February 2021 appellant-opponent 2 contested the the decision under appeal with respect to the findings concerning novelty and inventive step of the claims of auxiliary request 1 as filed before the opposition division.

With the reply to the appeals the respondent-patent proprietor maintained auxiliary request 1 as filed before the opposition division as main request. The respondent-patent proprietor argued inter alia (see reply, pages 5-6, bridging paragraph) that claim 1 of this request as well as claim 1 as originally filed referred to a matrix layer comprising a reservoir layer without reference to any additional layer so that both defined monolayer matrices wherein the reservoir layer represents the self-adhesive matrix layer and that the definition of a matrix layer comprising a reservoir layer having a coating weight of 150 g/m2 did therefore not introduce subject-matter extending beyond the original disclosure. With the reply the respondent-patent proprietor also filed auxiliary request 1-18.

V. The Board invited the parties to attend oral proceedings with the summons of 12 July 2021.

In the communication pursuant to Article 15(1) RPBA of 28 October 2021 the Board observed inter alia that it seemed questionable in view of the omission of the originally defined coating weight of the matrix layer whether claim 1 of the main request complied with Article 123(2) EPC (see section 2.1.3 of the communication). The Board indicated that this observation appeared also relevant to auxiliary requests 1, 2, 4-6, 8-10, 12-14 and 16-18. The Board further informed that it intended not to admit auxiliary requests 3, 7, 11 and 15 having regard to the principle of prohibition of reformatio in peius.

Appellant-opponent 1 announced in its letter of 29 April 2022 not to attend the oral proceedings.

In reply to the Board's communication and in preparation of the oral proceedings the respondent-patent proprietor argued in its letter of 31 May 2022 that the objection under Article 123(2) EPC regarding the omission of the definition of the coating weight of the matrix layer was for the first time raised in the statement of grounds of appeal filed by appellant-opponent 1. In its view the objection should therefore not be admitted into the appeal proceedings. With the letter of 31 May 2022 the respondent-patent proprietor also filed auxiliary requests 19-33.

The oral proceedings were held on 24 June 2022.

VI. Claim 1 of auxiliary request 1 defines with respect to claim 1 of the main request the additional feature:

"and the reservoir layer contains at least one amine-resistant silicone pressure sensitive adhesive."

Claim 1 of auxiliary request 2 defines with respect to claim 1 of auxiliary request 1 the additional feature:

"and rotigotine and polyvinylpyrrolidone are contained in the transdermal therapeutic system in a multitude of microreservoirs."

Claim 1 of auxiliary request 3 defines with respect claim 1 as granted the additional feature:

"wherein the transdermal therapeutic system is prepared by a method wherein a solvent system consisting of an aprotic polar solvent and a protic polar solvent in a ratio of 2:1 to 9:1 is used."

Claim 1 of auxiliary request 7 corresponds to claim 1 of auxiliary request 3 in which the solvent system is defined as "consisting of ethyl acetate and ethanol in a ratio of 2:1 to 9:1".

Claim 1 of auxiliary requests 11 defines a method for the preparation of a TTS defined in terms of auxiliary request 3 as follows:

"Method for the preparation of a transdermal therapeutic system comprising

(a) a backing layer,

(b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and

(c) a release liner,

wherein the self-adhesive matrix layer has a coating weight of about 100-400 g/m2 and comprises a reservoir layer containing about 9-20 wt.-% rotigotine based on the weight of the reservoir layer, and wherein a solvent system consisting of an aprotic polar solvent and a protic polar solvent in a ratio of 2:1 to 9:1 is used."

Claim 1 of auxiliary requests 15 corresponds to claim 1 of auxiliary request 11 in which the solvent system is defined as "consisting of ethyl acetate and ethanol in a ratio of 2:1 to 9:1".

Auxiliary requests 4, 8, 12 and 16 combine in independent claim 1 the respective amendments of auxiliary request 3, 7, 11 and 15 with the amendment of claim 1 of the main request.

Auxiliary requests 5, 9, 13 and 17 combine in independent claim 1 the respective amendments of auxiliary request 3, 7, 11 and 15 with the amendment of claim 1 of auxiliary request 1.

Auxiliary requests 6, 10, 14 and 18 combine in independent claim 1 the respective amendments of auxiliary request 3, 7, 11 and 15 with the amendment of claim 1 of auxiliary request 2.

Auxiliary requests 19-33 combine in independent claim 1 the respective amendments of the main request and auxiliary requests 1, 2, 4-6, 8-10, 12-14 and 16-18 with the additional feature:

"the self adhesive matrix layer has a coating weight of about 100-400 g/m2".

VII. The arguments presented on behalf of the appellant-opponents in as far as relevant to the present decision are summarized as follows:

The argument in the statement of grounds of appeal filed by respondent 1 that claim 1 of the main request did not comply with Article 123(2) EPC, because it defined the coating weight of the reservoir layer instead of the matrix layer as a whole, represented merely the development of the objection under Article 123(2) EPC as originally raised before the opposition division in reaction to the findings in the decision under appeal. In contrast, the respondent amended its appeal case by raising the issue admittance of this argument for the first time in its letter of 31 May 2022.

The application as originally filed only disclosed the defined TTS with a coating weight of the matrix layer of 75-400 g/m**(2). This feature was of technical significance, because due to practical constrains this weight cannot be arbitrarily chosen. Claim 1 of the main request comprised subject-matter which was not disclosed in the application as filed as a result of the omission of the originally defined limitation of the coating weight of the matrix layer. The main request did therefore not comply with Article 123(2) EPC.

Auxiliary requests 1, 2, 4-6, 8-10, 12-14 and 16-18 did not comply with Article 123(2) for the same reason as the main request.

Auxiliary requests 3, 7, 11 and 15 were not admissible in view of the principle of prohibition of reformatio in peius.

Auxiliary requests 19-33 were not to be admitted under Article 13(2) RPBA 2020.

VIII. The arguments of the respondent-patent proprietor relevant to the present decision are summarized as follows:

The argument that claim 1 of the main request did not comply with Article 123(2) EPC due to the omission of the definition of the coating weight of matrix layer had not been raised before the opposition division. This argument therefore represented an unjustified amendment to the appellants' case, which should not be admitted in view of Articles 12(2) and 12(4) RPBA 2020.

The application as filed described on pages 13-14 (bridging paragraph) a TTS without any particular limitation of the coating weight of the matrix layer. The original disclosure further specified on page 17 (lines 29-32), page 18 (lines 15-21) and page 31 (lines 1-8) preferred embodiments in which the matrix layer comprises a reservoir layer with the coating weight, the rotigotine content and the rotigotine to PVP weight as defined in claim 1 of the main request. The main request therefore complied with Article 123(2) EPC.

Auxiliary requests 19-33 were filed in reaction to the communication of 28 October 2021, in which the Board questioned whether the claims allowed by the opposition division complied with Article 123(2) EPC. These requests were admissible in analogy with the considerations in G 1/99, according to which a request for an amendment introducing one or more originally disclosed features in order to overcome an objection raised during the appeal proceedings was exceptionally admissible. The requests further overcame prima facie the Board's concerns regarding the issue of added matter and did not give rise to any new objections.

IX. Appellant-opponents 1 and 2 requested that the decision under appeal be set aside and that the patent be revoked in its entirety. Appellant-opponent 2 also requested that auxiliary requests 3, 7, 11 and 15 as well as auxiliary requests 19 to 33 not be admitted into the appeal proceedings.

X. The respondent-patent proprietor requested that the appeals be dismissed. Subsidiarily the respondent requested that the patent be maintained on the basis of one of auxiliary requests 1-18 as filed with the reply to the appeals or auxiliary requests 19-33 as filed with the letter of 31 May 2022.

The respondent-patent proprietor further requested that the argument under Article 123(2) EPC raised by the appellant-opponent 1 relating to the omission of the coating weight of the entire self-adhesive matrix layer not be admitted into the proceedings.

Main request

1. Article 123(2) EPC

1.1 Claim 1 of the main request defines:

"Transdermal therapeutic system, comprising

(a) a backing layer,

(b) a solvent-based self-adhesive matrix layer containing rotigotine as active ingredient, and

(c) a release liner,

wherein the self-adhesive matrix layer [deleted: has a coating weight of about 75-400 g/m2 and] comprises a reservoir layer [deleted: containing about 9-25 wt.-% rotigotine based on the weight of the reservoir layer], the reservoir layer has a coating weight of 150 g/m2 and contains 9 wt.-% or 18 wt.-% rotigotine based on the weight of the reservoir layer, and the reservoir layer further contains polyvinylpyrrolidone and the rotigotine to polyvinylpyrrolidone weight ratio in the layer is 9:2 to 9:5 or multiples thereof."

The Board's underlining and striking of definitions identify the amendments with respect to claim 1 as originally filed.

1.2 Request regarding the admittance of the objection

The argument that claim 1 of the main request comprised subject-matter extending beyond the content of the application as originally filed, because this claim defined the coating weight of the reservoir layer, but not the matrix layer as a whole, had been presented by appellant-opponent 1 in its statement of grounds of appeal (see pages 7-8 section II.1.2).

The respondent contested this objection on substantial grounds in the reply to the appeals and only questioned the admittance of the objection in the letter of 31 May 2022. At that time the Board had already issued the summons to oral proceedings and its communication pursuant to Article 15(1) RPBA 2020. The respondent's request not to admit the objection therefore represents an amendment to the respondent's appeal case which is in accordance with Article 13(2) RPBA 2020, in principle, not to be taken into account unless cogent reasons justify exceptional circumstances for consideration of the late amendment. The Board does not recognize any such justification in the respondent's submissions. The circumstance that in line with the argument in the statement of grounds of appeal filed by opponent respondent 1 the Board questioned in its communication the correctness of the finding in the decision under appeal can in this context not be qualified as exceptional.

The Board further observes that according to the minutes of the oral proceedings before the opposition division (see page 1, lines 18-20) appellant-opponent 2 objected that claim 1 of the auxiliary request 1 as filed in preparation of the oral proceedings before the opposition division, corresponding to the main request in appeal, comprised added subject-matter and that in particular the feature of the weight ratio of the PVP and rotigotine in the reservoir ratio was discussed. In the decision under appeal the opposition division concluded, however, that the defined subject-matter was adequately based on originally disclosed convergent limitations representing a restriction towards the original core invention (see pages 6-7, section 3.1). In this context the Board considers the argument regarding the coating weight of the matrix layer in the statement of grounds of appeal filed by appellant-opponent 1 not as an amendment of the opponents' case, but as a development of the objection as already raised before the opposition division in reaction to the findings in the decision under appeal.

Accordingly, even if the question of admittance raised by the respondent is taken into account, the Board still considers the relevant argument to be part of the appeal proceedings under Article 12(2) RPBA 2020.

1.3 Assessment of the basis for the amendments

1.3.1 As indicated in section 1.1 above, the amendment in claim 1 of the main request involves with respect to claim 1 as originally filed the omission of the definition of the coating weight of 75-400 g/m**(2)for the entire self-adhesive matrix layer and the introduction of definitions regarding the constitution of the reservoir layer, including its coating weight.

The definition of a coating weight of 150 g/m**(2)for the reservoir layer in claim 1 of the main request does not imply a corresponding restriction of the coating weight of the self-adhesive matrix layer as a whole. In fact, this matrix layer may in addition to the defined reservoir layer with a coating weight of 150 g/m**(2) contain additional layers, including further reservoir layers or a skin adhesive layer (see the patent, paragraphs [0071] and [0076], see also claim 2 of the main request). Accordingly for claim 1 of the main request to comply with Article 123(2) EPC an adequate basis for both the omission and the introduction of the indicated features must be identifiable in the application as originally filed.

1.3.2 According to the respondent the following passages in the original disclosure describe a TTS with a reservoir layer as defined in claim 1 of the main request without requiring a particular limitation of the coating weight of the matrix layer:

"In one embodiment, the self-adhesive matrix layer comprises a reservoir layer. The reservoir layer represents a matrix layer and is formed by a solid dispersion in terms of the foregoing. In a preferred embodiment, the self-adhesive matrix layer only comprises one reservoir layer and does not contain any additional matrix layer, i.e., in a preferred embodiment, the self-adhesive matrix layer represents a "mono -layer" matrix."(see page 17, lines 29-36)

"In a further embodiment, the reservoir layer of the transdermal therapeutic system has a coating weight of about 75-300 g/m2, preferably about 75-200 g/m2, more preferably about 100-150 g/m2 and most preferably about 150 g/m 2 and contains about 9-25 wt.-% rotigotine, preferably about 9-20 wt.-% rotigotine, more preferably about 9 wt.-% or about 18 wt.-% rotigotine based on the weight of the reservoir layer." (see page 18, lines 15-21)

"In a preferred embodiment, the self-adhesive matrix layer of the transdermal therapeutic system of the present invention comprises a reservoir layer and the reservoir layer contains rotigotine and polyvinylpyrrolidone and the rotigotine to polyvinylpyrrolidone weight ratio in the reservoir layer is 9:2 to 9:5, preferably 9:3 to 9:5, and particularly preferred 9:4, or multiples thereof." (see page 31, lines 1-8)

1.3.3 The Board notes that the passages cited by the respondent explicitly concern embodiments involving a particular constitution of the "the self-adhesive matrix layer" and "the reservoir layer" and thereby evidently refer to a generic antecedent in the disclosure.

According to the respondent the skilled person would recognize that the mentioned embodiments refer to the generic definition of a TTS requiring no particular range for the coating weight of the matrix layer presented in the following passage of the application as originally filed:

"The term "transdermal therapeutic system" (TTS) as used herein refers to a matrix-type patch having a continuous self-adhesive matrix layer in its centre portion. Such a patch consists of a backing layer, the self-adhesive matrix layer and a release liner, which is removed before use. In the present application, the terms "transdermal therapeutic system" , "TTS" and "patch" are equivalently used in order to describe the transdermal therapeutic system of the present invention" (see pages 13-14, bridging paragraph) "

The Board observes, however, that this passage presents merely the definition of what is intended with the term "transdermal therapeutic system" (TTS) in the context of the original disclosure. This definition provides information concerning the TTS described in the application as filed, but does as such not represent itself the generic antecedent for the subsequently disclosed embodiments. According to the Board the actually disclosed generic antecedent for the mentioned embodiments is to be found in the presentation of the invention preceding the definition of the used terminology (see page 13, lines 14-23), which recites the very same features as claim 1 as originally filed, including the feature limiting the coating weight of the matrix layer to 75-400 g/m**(2).

The Board therefore considers that the TTS defined in claim 1 of the main request without specific limitation of the coating weight of the matrix layer cannot be directly and unambiguously derived from the application as originally filed. Accordingly, the Board concludes that claim 1 of the main request does not comply with Article 123(2) EPC.

Auxiliary requests 1-18

2. Auxiliary requests 1, 2, 4-6, 8-10, 12-14 and 16-18

The coating weight of the matrix layer as a whole is not further defined in claim 1 of any of auxiliary requests 1, 2, 4-6, 8-10, 12-14 and 16-18. These auxiliary requests do therefore not comply with Article 123(2) EPC for the same reason as explained above in section 1.3 in relation to the main request.

3. Auxiliary requests 3, 7, 11 and 15

The respondent has not filed an appeal of its own against the decision under appeal, in which the claims of the main request (then auxiliary request 1) were held allowable. In accordance with the principle of prohibition of reformatio in peius as recognized in G 9/92 and G 1/99 the respondent is therefore in principle restricted to defending the patent within the limits of the subject-matter as defined in the main request.

The subject-matter defined in accordance with the claims of auxiliary requests 3, 7, 11 and 15 is not restricted by the limiting features of the coating weight of the reservoir layer, the content of the rotigotine and the weight ratio between the rotigotine and PVP as defined in the in claim 1 of the main request. These requests thus include claims to subject-matter which extends at least partially beyond the subject-matter defined in the claims of the main request. Accordingly, these requests fall under the prohibition of reformatio in peius and are therefore not admitted into the appeal proceedings.

The Board observes in this context that the exception to the prohibition of reformatio in peius formulated in G 1/99 concerns a remedy in appeal proceedings in case of the introduction of an impermissible limiting amendment, which had been held allowable by the opposition division (see point 14 of the Reasons). In contrast, the amendment held allowable by the opposition division in the present case involves, as explained in section 1.3 above, the impermissible omission of a limiting feature. The exception formulated in G 1/99 does therefore not apply to the present case.

Accordingly, auxiliary requests 3, 7, 11 and 15 are not admitted into the appeal proceedings.

Auxiliary requests 19-33

4. Admittance under Article 13(2) RPBA 2020

4.1 Auxiliary requests 19-33 were filed with the respondent's letter of 31 May 2022 well after the Board had issued the summons to oral proceedings and its communication pursuant to Article 15(1) RPBA 2020.

The filing of auxiliary requests 19-33 thus represents an amendment to the respondent's case which is in accordance with Article 13(2) RPBA 2020 in principle not to be taken into account unless cogent reasons justify exceptional circumstances for taking these requests into consideration.

4.2 The respondent argued that auxiliary requests 19-33 were filed in reaction to the communication of 28 October 2021, in which the Board questioned whether the claims allowed by the opposition division complied with Article 123(2) EPC. The Board observes, however, that in section 2.1.3 of its communication the Board did not introduce any new argument, but merely expressed its preliminary assessment with respect to the objection under Article 123(2) as presented in the statement of grounds of appeal filed by appellant-opponent 1. The circumstance that in view of the arguments in the appellant's statement of grounds of appeal the Board questioned the correctness of the assessment of the opposition division cannot be regarded as exceptional.

4.3 The respondent further referred to the considerations in G 1/99, in which a request for an amendment introducing one or more originally disclosed features was exceptionally considered admissible in order to overcome an objection raised during the appeal proceedings. The Board observes, however, that the considerations in G 1/99 merely concern the exception to the principle of prohibition of reformatio in peius in appeal proceedings. This exception only relates to the content of requests intended to remedy the impermissible introduction of a limiting amendment and is therefore unrelated to the exceptional circumstances for the admittance of late amendments to a party's appeal case under Article 13(2) RBPA 2020.

4.4 For the sake of completeness the Board further notes that the feature of a coating weight of 100 to 400 g/m**(2) for the matrix layer as introduced in the independent claims of auxiliary requests 19-33 does not seem consistent with the feature that this matrix layer comprises a reservoir layer with a coating weight of 150 g/m**(2). Accordingly, auxiliary requests 19-33 do not prima facie overcome the objection under Article 123(2) EPC against the main request and auxiliary requests 1-2, 4-6, 8-10, 12-14 and 16-18 without giving rise to any new objection.

4.5 Accordingly, the Board concludes that the respondent has not presented cogent reasons for exceptional circumstances justifying the late submission of auxiliary requests 19-33. These requests are therefore not admitted into the appeal proceedings.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility